| Literature DB >> 31388499 |
Sholapuri Payani1,2, Cherlopalli Mamatha1,2, Chinta Chandraprakash1,2, Matcha Bhaskar1,2.
Abstract
The present study was sought to evaluate the oxidative, antioxidant status and histopathological changes by the acute chronic exposure of formaldehyde. Bronco-T a poly-herbal formulation treatment, changes the oxidative, antioxidant status and histopathology of rat lungs with antioxidant and regenerative property. In this experiment thirty adult male albino Wister rats were used for the study and subdivided in to five groups consist of 6 rats for each group. Group-I served as control and the other 4 groups such as II, III, IV and V are considered as experimental. The control and treatment rats are maintained for 21 days of experimental period. Experimental rats are exposed to 40 percent formaldehyde for 1 h treated with Bronco-T and salbutamol. In the present investigation, the formaldehyde exposed rats a series of free radical chain reactions were grimly provoked, the evaluation of antioxidant enzymes (SOD, CAT), other enzymes oxidative enzymes (G-6-PDH, SDH) and (ALT, ALAT and LDH) were measured. A clear assertive imbalance between oxidation and anti-oxidation status was critically observed, and oxidative stress was clearly exacerbated in lung tissue leading to altrations in architecture of lung histopathology. Oral gavage Bronco-T exhibits a beneficial action by bringing normal architecture in lung tissue of formaldehyde inhaled rats with antioxidant properties. Bronco-T treatment may be a suitable remedy for formalin occupational diseases.Entities:
Keywords: Antioxidant status; Bronco-T; Formaldehyde; Polyherbal
Year: 2019 PMID: 31388499 PMCID: PMC6667771 DOI: 10.1016/j.toxrep.2019.07.002
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Showing the levels of Antioxidant and Oxidative Enzymes in lung tissue of Control and Experimental rats.
| Parameter | Group I | Group II | Group III | Group IV | Group V |
|---|---|---|---|---|---|
| SOD superoxide anion reduced/ mg protein/min. | 9.52 ±1.01 | 10.01 ±1.06(+5.14) | 5.01 ±0.59 (-47.26) | 8.54 ±0.71 (-10.29) | 7.42 ±0.41 (-22.05) |
| N.S | P<0.001 | P<0.001 | P<0.001 | ||
| CAT (μmoles of H2O2 metabolized/mg protein/min) | 68.56 ±7.34 | 69.63 ±7.26 (+1.56) | 48.25 ±5.74 (-29.62) | 59.86 ±5.16 (-12.69) | 52.21 ±4.47 (-23.84) |
| N.S | P<0.001 | P<0.001 | P<0.001 | ||
| AAT (μ moles of pyruvate formed/ mg protein / min) | 8.44 ±0.81 | 8.41 ±0.85 (-0.35) | 5.82 ±0.69 (-31.04) | 7.10 ±0.72 (-15.87) | 6.91 ±0.48 (-18.12) |
| N.S | P<0.001 | P<0.001 | P<0.001 | ||
| ALAT (μ moles of pyruvate formed/ mg protein / min) | 0.98 ±0.29 | 0.79 ±0.06 (-19.38) | 0.23 ±0.022 (-76.53) | 0.92 ±0.08 (-6.12) | 0.66 ±0.14 (-32.65) |
| P<0.001 | P<0.001 | N.S | P<0.001 |
Values are mean ± S.D. of 6 individual rats.
Values are significantly different from control at P < 0.001; NS indicates no significant change.
Showing the alterations in Oxidative Enzymes activities in Lung tissue of Control and Experimental rats.
| Parameter | Group I | Group II | Group III | Group IV | Group V |
|---|---|---|---|---|---|
| G-6-PDH (μ moles of formazon formed/ mg protein /min) | 4.65±0.48 | 4.47 ±0.36 (-3.87) | 3.00 ±0.32 (-35.48) | 4.35 ±0.33 (-6.45) | 3.63 ±0.36 (-21.93) |
| NS | P<0.001 | P<0.001 | P<0.001 | ||
| LDH (μ moles of formazon formed/ mg protein /min) | 4.14 ±0.42 | 4.06 ±0.33 (-1.93) | 0.49 ±0.052 (-88.16) | 3.48 ±0.21 (-15.94) | 2.22 ±0.21 (-46.37) |
| NS | P<0.001 | P<0.001 | P<0.001 | ||
| SDH (μ moles of formazon formed/ mg protein / min) | 12.12 ±0.91 | 11.55 ±0.81 (4.70) | 1.20 ±0.12 (-90.09) | 11.45 ±1.02 (-5.52) | 9.41 ±0.93 (-22.21) |
| NS | P<0.001 | NS | P<0.001 |
Values are mean ± S.D. of 6 individual rats.
Values are significantly different from control at P < 0.001; NS indicates no significant change.
Showing the electrolytes weight and atomic percentage in Broncho – T.
| 1 | O K | 85.18 | 93.24 |
| 2 | Cl K | 3.10 | 1.53 |
| 3 | K K | 9.88 | 4.42 |
| 4 | Ca K | 1.84 | 0.81 |
| Totals | 100 | 100 |
Fig. 1A) Showing SOD levels in lung tissue of control and experimental animals. B) Showing % change of SOD activity in lung tissue of experimental animals. C) Showing catalase levels in lung tissue of control and experimental animals. D) Showing % change of Catalase activity in lung tissue of experimental animals. E) Showing AAT levels in lung tissue of control and experimental animals. F) Showing % change of AAT activity in lung tissue of experimental animals. G) Showing ALAT levels in lung tissue of control and experimental animals. H) Showing % change of ALAT activity in lung tissue of experimental animals.
Fig. 2A) Showing the levels of G6PDH enzyme in lung tissue of control and experimental animals. B) Showing % change of G6PDH activity in lung tissue experimental animals. C) Showing the levels of LDH activity in lung tissue of control. and experimental animals. D) Showing % change of LDH activity in lung tissue of experimental animals. E) Showing the levels of SDH activity in lung tissue of control and experimental animals. F) Showing % change of SDH activity in lung tissue of control and experimental animals.
Fig. 3A) Scanning Electronic Microscopic Image. B) EDX elemental composition Quantitative Analysis. C) Spectrum processing Histological Procedure.
Fig. 4A) Normal Cyto-architecture of lung tissue in control rats (10X magnification). B) Normal architecture of lung tissue on treatment with Bronco-T (10X magnification). C) Shows hemarages and congestion leading to structural of lung on expose to formaldehyde (10X magnification). D) Shows Regenerative changes in lung was observed similar to normal architecture of lung on treatment with Bronco-T (10X magnification). E) Shows Regeneration of lung tissue similar to normal architecture of lung on treatment with Salbutamol (10X magnification).